Rapid Response Opportunities
Rapid response opportunities have an internal deadline under 60 days.
Deadline Extended! The internal competition deadline for a new Phase I CoBRE has been extended to December 1, 2018 for consideration of submission January 2020. Please contact Paula Turpen in the Research Office if you have questions.
UNMC is eligible to compete for research support through the NIH NIGMS Institutional Development Award (IDeA) program. One of the principal mechanisms of IDeA support of research is the Center of Biomedical Research Excellence (COBRE) grant.
NIGMS has issued an RFA announcing new rounds of COBRE competition in 2019. UNMC has a long-standing history of competing successfully for these $10M awards. UNMC is now eligible to submit an application for a new COBRE program.
Only one proposal may be submitted per eligible institution per fiscal year. The eligible institution is responsible for selecting and approving that project before it can be submitted.
The Office of the Vice Chancellor for Research evaluates potential UNMC proposals for COBRE grants; therefore, we are soliciting outlines of prospective projects that could be developed into full-scale COBRE proposals for the January, 2020 deadline.
Interested investigators may submit a two-page outline of their project that summarizes how they propose to address each of the CoBRE components. The outline should follow this template format. CoBRE Criteria can be found here.
These 2-page summaries are due to Deborah Hawkins (email) on December 1, 2018.
From these summaries, UNMC Deans and Directors (or their designate) will identify the project to be developed into a full COBRE proposal for submission by January, 2020. Questions can be directed to Paula Turpen, email or 402-559-6162
This grant program is aimed at encouraging new users to employ NU core facilities in their research. The program is open to all faculty from any of the NU campuses. Awards are intended to be used to gather new or additional data for strengthening a grant proposal (new or resubmission) or for addressing reviewer concerns associated with a peer-reviewed manuscript.
Eligibility: Any faculty member (Assistant, Associate or Full Professors and equivalent-rank researchers) employed by any University of Nebraska campus is eligible to submit funding applications if they (or students/staff within their research group) have not used a specific core facility (or new technology platform within a core) during the last two fiscal years (2016-2017, 2017-2018) and who require these services to generate data to support new/resubmitted grants or resubmitted/revised manuscripts. Existing core users that request the same technologies/services from other cores (for example, standard electron microscopy on a different campus) are not considered new users.
Application Process: Applications must be submitted electronically via grants-awards.nebraska.edu. Download RFA information, including restrictions, reporting requirements, and detailed application instructions here.
Amount: The maximum request is $5,000 per core facility and a total of $9,000 per new user if more than one core facility is to be used.
Deadline: Proposals will be reviewed quarterly during the first 3 quarters of the fiscal year (July/August, October/November, and January/February). Please allow 2 – 3 weeks for review and decision on the proposal. Note that funds must be used by June 30, 2019; no new award will be made after March 31, 2019.
For more information about the campus cores on any campus or applications for this program, please contact your campus' research office. (UNMC: Paula Turpen, email or 402-559-6162)
The Buffett Cancer Center is pleased to announce a new FPBCC bridge funding program intended to support the research of Cancer Center members who have received encouraging scores that fell below the funding threshold on recent cancer-focused grant applications. The purpose of this program is to support the efforts necessary to produce additional data for promising cancer research projects, in order to strengthen related proposal resubmissions to federal funding agencies.
The Buffett Cancer Center is primarily seeking to support proposals submitted after February 2017 that fit within the following criteria:
- New (A0) applications that received priority scores outside of the granting agency's current pay line; or
- Grants that have been submitted for competitive renewal and received a competitive but non-fundable score within two years from the expiration of the current award.
Eligibility for bridge funding extends to all Fred & Pamela Buffett Cancer Center Members who are applying for or renewing individual investigator awards, multi-investigator awards, center grants, and program project grants from federal funding agencies and/or nationally peer-reviewed organizations. Funding priority will be given to those who submitted applications to the NCI, followed by those with cancer-focused proposals submitted to other NIH institutes or other federal agencies.
To be considered for this opportunity, please review the request for applications available at: https://unmc.edu/cancercenter/research/research-funding-opp.html. Applications must be prepared in accordance with the guidelines outlined in the RFA and submitted as a single, complete PDF to both Matt Winfrey (firstname.lastname@example.org) and Kelly Jordan (email@example.com). Proposals requesting bridge funding will be accepted on a rolling basis.Cancer Center leadership will review all submissions to identify promising candidates for bridge funding. It is the expectation of the Buffett Cancer Center that those competitive proposals selected for support will be able to move into the fundable scoring range during the following funding cycle.
The Online Partnership to Accelerate Research (OnPAR) was conceived to re-accelerate the biomedical research and development enterprise by seeking a larger return on NIH's peer review investment on research proposals evaluated in the top 30% in each NIH Institute and Center. The goal of OnPAR is to match quality biomedical research projects with priority areas of interest of private foundations, and pharmaceutical and biotech companies and/or other private biomedical research funders.
How to Apply
Leidos has worked with NIH Program Officers to inform applicant Principal Investigators that have scored well, but below the Institute/Center payline, about OnPAR. If an applicant scored in the top 30% and is not funded by NIH, he/she is welcome to submit an abstract for consideration. Qualified applicants are invited to register with OnPAR and participate in the submission and review process. It is not necessary to re-write an application. OnPAR will accept the NIH abstract that was submitted by the applicant, and if invited, his/her submitted NIH application and Summary Statement.